Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.42). Revenue for the quarter came in at $20 million.

For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.